J Clin Immunol. 2026 Mar 31. doi: 10.1007/s10875-026-02007-z. Online ahead of print. NO ABSTRACT PMID:41917218 | DOI:10.1007/s10875-026-02007-z
J Clin Immunol. 2026 Mar 29. doi: 10.1007/s10875-026-02010-4. Online ahead of print. NO ABSTRACT PMID:41904735 | DOI:10.1007/s10875-026-02010-4
J Clin Immunol. 2026 Mar 28. doi: 10.1007/s10875-026-02015-z. Online ahead of print. NO ABSTRACT PMID:41896320 | DOI:10.1007/s10875-026-02015-z
J Clin Immunol. 2026 Mar 29. doi: 10.1007/s10875-026-02012-2. Online ahead of print. NO ABSTRACT PMID:41904308 | DOI:10.1007/s10875-026-02012-2
J Clin Immunol. 2026 Mar 28. doi: 10.1007/s10875-026-02008-y. Online ahead of print. ABSTRACT PURPOSE: Congenital athymia is a life-threatening condition characterized by thymic absence and profound T-cell immunodeficiency. Thymus implantation is the definitive treatment, but its availability is limited. This study aimed to evaluate the outcomes of hematopoietic cell transplantation (HCT) as an alternative therapy. … Read more
J Clin Immunol. 2026 Mar 26. doi: 10.1007/s10875-026-02003-3. Online ahead of print. ABSTRACT PURPOSE: Pathogenic variants in the T-cell receptor alpha constant (TRAC) gene have been primarily associated with combined immunodeficiency (CID). To date, only five patients from three unrelated families harboring the same TRAC variant with a CID phenotype, and three patients carrying a … Read more
J Clin Immunol. 2026 Mar 26. doi: 10.1007/s10875-026-02011-3. Online ahead of print. NO ABSTRACT PMID:41882201 | DOI:10.1007/s10875-026-02011-3
J Clin Immunol. 2026 Mar 24. doi: 10.1007/s10875-026-02006-0. Online ahead of print. NO ABSTRACT PMID:41874828 | DOI:10.1007/s10875-026-02006-0
J Clin Immunol. 2026 Mar 23. doi: 10.1007/s10875-026-02013-1. Online ahead of print. NO ABSTRACT PMID:41870648 | DOI:10.1007/s10875-026-02013-1
J Clin Immunol. 2026 Mar 21. doi: 10.1007/s10875-026-02001-5. Online ahead of print. NO ABSTRACT PMID:41863686 | DOI:10.1007/s10875-026-02001-5
